COVID-19 infection in Crohn’s disease under treatment with adalimumab | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

PostScript

Letter

COVID-19 infection in Crohn’s disease under treatment with adalimumab

Online download statistics by month:

Online download statistics by month: April 2020 to March 2024

	Abstract	Full	Pdf
Apr 2020	1557	1530	499
May 2020	1300	1245	483
Jun 2020	922	873	224
Jul 2020	1180	1156	147
Aug 2020	755	707	94
Sep 2020	887	756	66
Oct 2020	1404	1363	87
Nov 2020	828	791	69
Dec 2020	390	353	78
Jan 2021	902	867	89
Feb 2021	1016	971	67
Mar 2021	934	893	67
Apr 2021	860	809	90
May 2021	759	735	60
Jun 2021	355	340	48
Jul 2021	394	384	48
Aug 2021	599	590	34
Sep 2021	261	248	53
Oct 2021	234	217	46
Nov 2021	210	184	41
Dec 2021	410	401	31
Jan 2022	403	377	57
Feb 2022	136	122	39
Mar 2022	179	164	30
Apr 2022	166	155	21
May 2022	199	192	27
Jun 2022	176	169	15
Jul 2022	181	171	19
Aug 2022	131	123	18
Sep 2022	117	102	27
Oct 2022	129	125	14
Nov 2022	69	64	12
Dec 2022	84	78	7
Jan 2023	54	50	10
Feb 2023	82	82	6
Mar 2023	73	72	8
Apr 2023	77	7	1
May 2023	81	3	3
Jun 2023	110	3	0
Jul 2023	138	4	3
Aug 2023	238	5	6
Sep 2023	231	4	2
Oct 2023	152	5	4
Nov 2023	174	7	3
Dec 2023	118	7	1
Jan 2024	80	0	7
Feb 2024	64	2	9
Mar 2024	94	4	8
Total	19893	17510	2778